Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer

Abstract

This PDO-based platform captures important aspects of treatment-resistant pancreatic cancer and its metastatic features, suggesting that this study may serve as a tool for the discovery of personalized therapies.